台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股▼0.22%
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119)籌碼相關-中國信託-文心 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

中國信託-文心 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/170.184.0000.0084.200.12720.04%
2025/01/1300.00183.6083.90-1269-0.37%
2025/01/10187.1000.0085.8012590.39%
2025/01/0900.00189.1088.50-1251-0.40%
2025/01/021.190.2800.0090.201.12480.42%
2024/12/1800.000.190.8090.50-0.1244-0.05%
2024/12/16190.4000.0090.3012420.41%
2024/12/1300.000.491.5090.60-0.4238-0.17%
2024/12/0900.00594.5693.40-5224-2.22%
2024/12/0600.00297.4597.00-2220-0.91%
2024/12/0500.005397.8697.40-53218-24.23%
2024/12/0400.004797.8697.80-47216-21.70%
2024/12/03298.103297.7497.80-30216-13.83%
2024/12/0200.00596.9496.10-5204-2.45%
2024/11/29495.384195.4196.20-37199-18.50%
2024/11/2800.002094.9595.00-20197-10.10%
2024/11/2500.004097.7197.60-40187-21.37%
2024/11/21197.60197.5098.0001780.00%
2024/11/1900.000.195.9096.10-0.1155-0.06%
2024/11/1800.000.295.5096.00-0.2151-0.13%
2024/11/1500.000.295.5095.50-0.2147-0.14%
2024/11/1400.00194.9094.90-1142-0.70%
2024/11/13195.3000.0096.0011360.73%
2024/11/0800.000.290.0090.40-0.295-0.21%
2024/09/2700.00090.0089.8001350.00%
2024/09/1800.00088.0088.000151-0.02%
2024/08/3000.00488.0588.40-4171-2.33%
2024/08/2000.00289.5089.20-2181-1.10%
2024/08/12390.6000.0089.9032031.47%
2024/08/0700.00190.4090.50-1210-0.48%
2024/08/0500.00387.3086.60-3214-1.40%
2024/08/0100.00192.0092.20-1204-0.49%
2024/07/1800.005192.6392.70-51199-25.57%
2024/07/110.191.40191.4091.80-1203-0.47%
2024/07/0900.001091.7091.80-10205-4.86%
2024/07/0500.000.191.2091.30-0.1203-0.05%
2024/07/0400.000.491.5091.20-0.4205-0.18%
2024/07/0200.00290.6591.20-2206-0.97%
2024/06/2800.00590.2690.40-5205-2.43%
2024/06/17190.3000.0090.8012080.48%
2024/06/1300.00190.1090.00-1212-0.47%
2024/06/0700.004793.0293.10-47216-21.68%
2024/06/0500.005292.9892.90-52220-23.54%
2024/06/0400.001392.7292.50-13228-5.69%
2024/06/0300.002092.4092.40-20231-8.65%
2024/05/3100.001092.7092.00-10230-4.34%
2024/05/2800.003892.7092.50-38235-16.14%
2024/05/2700.005093.0093.10-50234-21.32%
2024/05/2400.004092.0391.90-40233-17.12%
2024/05/2200.002.692.5192.40-2.6235-1.10%
2024/05/1600.00192.0092.50-1225-0.44%
2024/05/1300.002091.9091.80-20232-8.59%
2024/05/0700.000.288.1088.10-0.2242-0.07%
2024/05/0600.00688.6088.50-6242-2.47%
2024/04/229586.1810086.1886.50-5254-1.97%
2024/04/1800.008688.6488.30-86250-34.40%
2024/04/1700.0014388.4588.40-143249-57.28% 大賣/鉅額交易
2024/04/1500.006488.2487.70-64252-25.36%
2024/04/1100.003388.9288.90-33261-12.60%
2024/04/1000.009589.5689.50-95261-36.28%
2024/04/0900.0010389.1988.90-103261-39.41% 大賣/鉅額交易
2024/04/088187.9010587.9288.00-24260-9.22% 大賣/
2024/04/0300.001188.1087.80-11258-4.25%
2024/04/0200.007188.9988.60-71259-27.40%
2024/04/0100.002588.8388.70-25257-9.72%
2024/03/292088.205888.2888.40-38258-14.70%
2024/03/2800.006088.4388.30-60258-23.23%
2024/03/2700.005687.7887.50-56259-21.54%
2024/03/268087.1013487.3687.20-54260-20.77% 大賣/
2024/03/2500.003487.6487.60-34261-13.00%
2024/03/2200.002587.5087.60-25265-9.43%
2024/03/2100.00987.8087.70-9274-3.28%
2024/03/2000.0011187.6487.60-111278-39.83% 大賣/鉅額交易
2024/03/1900.003088.1487.90-30280-10.68%
2024/03/140.287.5000.0087.200.22860.06%
2024/03/1200.0093.389.0789.00-93.3278-33.55%
2024/03/11189.206389.1989.10-62275-22.54%
2024/03/0800.007890.4690.40-78273-28.55%
2024/03/0600.00890.9090.90-8270-2.96%
2024/03/0500.001991.0890.90-19274-6.92%
2024/03/0400.00690.9090.90-6274-2.18%
2024/02/270.291.2500.0091.500.22810.08%
2024/02/1900.00091.3091.500285-0.02%
2024/02/15189.8000.0089.9012930.34%
2024/02/05191.1000.0091.1012910.34%
2024/02/0100.00193.8092.30-1299-0.33%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章